Literature DB >> 21108349

Persistence and clearance of HPV from the penis of men infected and non-infected with HIV.

R J C Silva1, J Casseb, M A Andreoli, L L Villa.   

Abstract

Due to high rates of human papillomavirus (HPV) infection, the incidence of intraepithelial neoplasia and anal cancer, most studies concerning HPV in men seropositive for HIV have focused on the anal canal. Few studies have targeted the penile region in HIV-infected men. A total of 72 men seropositive for HIV and 72 men seronegative for HIV were followed-up for 6 months, and their penile exfoliated cells were tested for HPV DNA. There were no significant differences between the HIV-positive and HIV-negative men in persistence (respectively, 69.5% vs. 66.9%), clearance (respectively, 15.3% vs. 23.1%), and those men never infected with HPV during the four follow-up visits (15.2% for HIV-positive vs. 20% for HIV-negative). High-risk HPV types were detected more frequently in penile smears from men infected with HIV, while, in HIV-seronegative men, the low-risk HPV types were more abundant (P = 0.001). Multiple infections with both high- and low-risk HPV types were significantly more frequent in HIV-seropositive compared to those who were HIV-seronegative (P = 0.0004). The attendance rates at follow-up visits were 86%, 78%, and 58% in months 1, 2, and 6, respectively, for men infected with HIV and 93%, 72%, and 60% for the HIV-negative group. It is concluded that HIV infection can be considered a risk factor for clearance and persistence of HPV. Multiple infections with different types of HPV including high-risk HPVs are frequent in men who are infected with HIV.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21108349     DOI: 10.1002/jmv.21950

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  The natural history of genital human papillomavirus among HIV-negative men having sex with men and men having sex with women.

Authors:  Alan G Nyitray; Mihyun Chang; Luisa L Villa; Roberto J Carvalho da Silva; Maria Luiza Baggio; Martha Abrahamsen; Mary Papenfuss; Manuel Quiterio; Jorge Salmerón; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  J Infect Dis       Date:  2015-02-03       Impact factor: 5.226

2.  Brazilian Protocol for Sexually Transmitted Infections 2020: human papillomavirus (HPV) infection.

Authors:  Newton Sergio de Carvalho; Roberto José de Carvalho da Silva; Isabel Cristina do Val; Maria Luiza Bazzo; Mariângela Freitas da Silveira
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

3.  Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status.

Authors:  Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

4.  Human papillomavirus prevalence and behavioral risk factors among HIV-infected and HIV-uninfected men who have sex with men in Taiwan.

Authors:  Chia-Chun Lin; Ming-Chang Hsieh; Hung-Chang Hung; Shih-Ming Tsao; Shiuan-Chih Chen; Hao-Jan Yang; Yuan-Ti Lee
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

5.  HPV-related external genital lesions among men residing in Brazil.

Authors:  Roberto Jose Carvalho da Silva; Staci Lynn Sudenga; Laura Sichero; Maria Luiza Baggio; Lenice Galan; Ricardo Cintra; Benji Nelson Torres; Mark Stoler; Anna Regina Giuliano; Luisa Lina Villa
Journal:  Braz J Infect Dis       Date:  2017-04-08       Impact factor: 3.257

6.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.